SMART-BMI Clinical Trial Links Oura Smart Ring to GLP-1 Weight Loss Outcomes
Oura has partnered with UC San Diego Health to launch the SMART-BMI clinical trial, investigating how biometric data captured by the Oura smart ring correlates with the results of GLP-1 treatments and weight-related surgical procedures. The study aims to track metrics such as weight loss, hemoglobin A1c levels, and treatment persistence during the gaps between traditional clinical visits.
Clinical Rigor and Regulatory Expansion at Oura
Oura Chief Medical Officer Ricky Bloomfield stated that the company is actively working to elevate the clinical rigor of its wearable technology. To support these efforts, Oura established the Office of Regulatory and Clinical Affairs, a dedicated department focused on clinical research, regulatory pathways, and health informatics. Jeff Reeves of UC San Diego Health noted that continuous remote monitoring can enhance long-term obesity management and surgical follow-up by supplying physicians with objective daily metrics.
Oura, UC San Diego Health collaborate to study GLP-1 outcomes using continuous smart ring data – Researchers want to determine whether changes in sleep, recovery, activity and other physiological signals provide useful information about how patients are responding to obesity…
Integration Across Independent Research and Hospital Networks
The Oura smart ring has already appeared in more than 200 peer-reviewed scientific publications, covering metrics like heart rate variability and sleep tracking. In addition to the new SMART-BMI trial, Oura is collaborating with the Johns Hopkins School of Medicine to examine early pathophysiological changes during recovery in acute kidney injury patients. Alex A. Khalessi, neurosurgeon and chief innovation officer at UC San Diego Health, emphasized that the hospital system provides an ideal environment for testing emerging medical technology.
Frequently Asked Questions
What specific metrics does the SMART-BMI trial track between clinic visits?
The trial monitors physiological changes such as weight loss trajectories, hemoglobin A1c fluctuations, and treatment persistence that are typically unmeasured during standard outpatient appointments.
Is the Oura smart ring classified as a regulated medical device?
No, Oura explicitly states that the Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent any disease or medical condition.
Which academic institutions are currently collaborating with Oura on clinical research?
Oura is working with UC San Diego Health on the SMART-BMI trial and has partnered with the Johns Hopkins School of Medicine to study recovery markers in acute kidney injury patients.
Keep reading